Purchase Order N6809623P0003

Award Date 10/5/22
Potential Completion Date 9/30/23
Potential Value $165K
Funding Federal Agency
Defense Health Agency
Contracting Federal Agency
Bureau of Medicine and Surgery
Ultimate Awardee
Lantheus Holdings, Inc.
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Agana Heights, Guam
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Health Agency (DHA) awarded a firm-fixed-price delivery order contract to Lantheus Medical Imaging, Inc. in the amount of $119,248.18. The contract is for the provision of TechneLite Generators, which are used to produce Technetium-99m, a critical radioisotope utilized in nuclear medicine imaging procedures. The contract supports the medical needs of the Tripler Army Medical Center in Hawaii and has a period of performance through September 30, 2024. This order is placed against...
This is a federal contract award to Lantheus Medical Imaging, Inc., a manufacturer of diagnostic medical imaging agents and products, by the Defense Health Agency. The contract, valued at $119,921.94, is for the delivery of TechneLite generators, which are used in nuclear medicine procedures. The contract is a delivery order placed against Lantheus' Pharmaceuticals and Drugs Schedule contract with the General Services Administration (GSA). No set-aside designation was used for this award....
This is a firm fixed-price delivery order awarded by the Defense Health Agency (DHA) to Lantheus Medical Imaging, Inc., a for-profit manufacturer of diagnostic medical imaging agents, nuclear medicine supplies, and radiopharmaceutical products. The $107,147.03 award is for the delivery of 4500X TECHNELITE MO/TC99M GENERATORS, medical imaging equipment used in diagnostic procedures. The contract was not set aside for small businesses. Lantheus Medical Imaging holds two significant Indefinite...
This is a firm fixed-price purchase order contract awarded by the Defense Health Agency (DHA) to Lantheus Medical Imaging, Inc. for the procurement of TechneLite Generators, which provide Technetium Tc 99m essential for diagnostic medical imaging procedures. The contract, valued at $51,621.64, will support the United States Naval Hospital (USNH) Guam with weekly shipments of these critical medical devices. Lantheus Medical Imaging, Inc. is the sole manufacturer and supplier of these TechneLite...
This delivery order, awarded by the Defense Health Agency on September 16, 2020, is for $132,940.80 to provide TechneLite 5000 TC99M generators with no set-aside designation. The prime contractor is Lantheus Medical Imaging, Inc., a for-profit manufacturer of radiopharmaceutical products. Lantheus will deliver the technetium-99m generators to support nuclear medicine procedures performed at military treatment facilities in Guam under the contract's November 30, 2023 completion date. This award...
This is a federal delivery order award made by the Defense Health Agency (DHA) to Lantheus Medical Imaging, Inc., a for-profit manufacturer of diagnostic medical imaging agents, nuclear medicine supplies, and radiopharmaceutical products. The award is for 4,500 TechneLite Mo/Tc99m generators, which are critical medical imaging equipment used in diagnostic procedures at military treatment facilities, VA medical centers, and other federal healthcare institutions. The contract is a firm fixed-price...
This is a firm fixed price purchase order contract awarded by the Department of the Army Medical Command to Lantheus Medical Imaging, Inc. for the provision of radiopharmaceuticals. The contract is valued at $141,137.33 and has a completion date of September 30, 2019. The contract was awarded on June 29, 2018 and is not set-aside. Lantheus Medical Imaging, a manufacturer of diagnostic medical imaging agents and products, is providing technetium-99m generators, xenon-133 gas, sestamibi vials, and...
The U.S. Defense Health Agency has awarded a firm-fixed-price definitive contract worth $811,119.92 to Lantheus Medical Imaging, Inc. to provide Technelite Generator MO99/TC99 5000 MCI units to the Dwight D. Eisenhower Army Medical Center in Fort Gordon, Georgia. This contract is set aside for small businesses. Lantheus Medical Imaging, a subsidiary of Lantheus Holdings, Inc., is a for-profit manufacturer of diagnostic medical imaging agents and products. The contractor will deliver FDA-approved...
This federal contract award to Lantheus Medical Imaging, Inc. is for the delivery of TECHNELITE GENERATOR 5000X, a nuclear medicine product. The contract, valued at $97,445.58, was issued on a firm-fixed-price basis by the Defense Health Agency, a component of the Department of Defense. The contract is a delivery order placed under Lantheus Medical Imaging's General Services Administration (GSA) Pharmaceutical and Drugs Schedule (FSS-61-IB) contract. This contract vehicle allows federal...
This is a firm fixed-price delivery order awarded by the Defense Health Agency (DHA) to Lantheus Medical Imaging, Inc., a for-profit manufacturer of diagnostic medical imaging agents and products. The contract is for the supply of TECHNELITE GENERATOR M099/TC99M, 7500MC equipment to the Tripler Army Medical Center in Hawaii. The total potential value of the contract is $53,347.87, with a completion date of September 30, 2023. The contract is issued under the Pharmaceuticals and Drugs (FSS-61-IB)...

The Defense Health Agency awarded a $164,605.48 firm fixed price purchase order to Lantheus Medical Imaging, Inc. to supply TechneLite generators from October 2022 through September 2023. This contract has no set-aside designation. Lantheus Medical Imaging is a for-profit manufacturer that provides radiopharmaceutical products, including technetium-99m generators, xenon-133 gas, and other nuclear medicine supplies, to federal agencies such as the Department of Veterans Affairs and Department of the Army. The contract was awarded against Lantheus' existing Pharmaceuticals and Drugs Schedule contract, which enables the Defense Health Agency to acquire standardized injectable radiotracers and related products for use in military treatment facilities.

Generated 3/21/24, 8:04 PM